STATH and neoplasm: The expression of STATH across 33 cancer types was analyzed via TIMER (Tumor Immune Estimation Resource), GEPIA (Gene Expression Profiling Interactive Analysis), and UALCAN (University of Alabama at Birmingham Cancer Data Analysis Portal), and promoter methylation and clinical correlations were explored in HNSCC.